NeoMag: Revolutionize your research with accurate biomechanical modeling

60Nd is reshaping the future of mechanomedicine with NeoMag®, a disruptive device that enables non-invasive, reversible, and precisely controlled mechanical stimulation of biological cells and tissues in both 2D and 3D cultures. Developed from ERC-funded research, NeoMag® integrates magneto-active smart materials, automated magnetic field actuation, and AI-driven software. The result is a novel product category addressing a critical unmet need in biomedical R&D. The lack of technologies to replicate physiologically relevant mechanical environments hampers drug development. NeoMag® enables early detection of failure risks linked to mechanical microenvironments, improving predictability and reducing costs.